Navigation Links
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
Date:4/30/2013

BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2013, which ended on March 31, 2013. 

For the three months ended March 31, 2013 consolidated service revenue increased by 27.7% to $454.5 million compared with $356.0 million in the prior year period.
Excluding the negative impact from foreign exchange movements in the current quarter of $2.2 million, revenue increased 28.3%.  Liquent, Inc. contributed $9.3 million to revenue in the quarter.  On a constant currency, same store basis, revenue growth was 25.7%.  Operating income as reported under Generally Accepted Accounting Principles (GAAP) totaled $36.6 million, or 8.1% of service revenue, in the third quarter of Fiscal Year 2013, as compared with $28.2 million, or 7.9% of service revenue, in the comparable quarter of the prior year.  GAAP net income for the quarter totaled $29.5 million, or $0.50 per diluted share, compared with a GAAP net income of $22.9 million, or $0.38 per diluted share for the quarter ended March 31, 2012.  GAAP diluted earnings per share grew 31.6% year-over-year.

The financial results of the March quarter in the current and prior periods each included special items, as detailed in the financial charts within this press release.  Excluding the impact of special items, adjusted operating income in the third quarter of Fiscal Year 2013 was $37.3 million, or 8.2% of service revenue.  Excluding the impact of special items, adjusted operating income in the third quarter of Fiscal Year 2012 was $30.0 million, or 8.4% of service revenue.  Adjusted net income in the current and prior period (which exclude the special items referenced above) was $29.5 million, or $0.50 per diluted share in the quarter ended March 31, 2013, and was $19.9 million, or
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. PAREXEL International to Present at J.P. Morgan Healthcare Conference
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
5. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
6. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
7. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
8. PAREXEL International to Present at Morningstar Conference
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
10. UV Flu Technologies Expands Its International Footprint
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... MINNEAPOLIS and REHOVOT, Israel , ... UK medical 3D printing specialist, Replica 3DM, supports NHS hospitals ... 3D Printers   - Performing surgery ... and anesthetic times; improves patient recovery and provides an effective ... Stratasys Ltd. (Nasdaq: SSYS ), a ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology ... the symbol (NUUU) has two (2) wholly- owned ... two subsidiaries harness scientifically advanced technology to provide ... NUUU,s Renuell Int,l, Inc. is launching ... skin care products that is made possible because ...
(Date:8/26/2014)... -- Trovagene, Inc. (NASDAQ:  TROV) presented data at ... to the Clinic with an oral presentation ... Tumor DNA in Urine." In this presentation Trovagene ... Monitoring (PCM) platform and results from several studies ... tumor DNA mutations from urine samples of cancer ...
(Date:8/26/2014)... 26, 2014 Albany Molecular Research Inc. (NASDAQ: ... S. Marth , President and Chief Executive Officer at ... Conference on Monday, September 8, 2014 at 8:45 a.m. ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") ... his research group at St. James,s University Hospital ... in the April 10 online issue of,Gene Therapy. ... by,Oncolytic Reovirus for the Treatment of Melanoma.", ...
... Technology (NIST), in collaboration with the National Aeronautics ... for making essential measurements on samples of single-walled ... current best practices for characterizing one of the ... generation of nanoscale materials. , The nanotubes are ...
... Inc. (Nasdaq: VION ) today announced that it ... The Nasdaq Capital Market,listing requirements, including the time frame ... announced that it had received a letter, dated,March 24, ... Company,that it does not comply with Marketplace Rule 4310(c ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2Carbon nanotube measurements: latest in NIST 'how-to' series 2Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3
(Date:8/26/2014)... have provided the first evidence that the lack ... early signs of dementia. , Published in ... absence of the protein MK2/3 promotes structural and ... These changes were shown to have a significant ... learning and memory formation capabilities. , An absence ...
(Date:8/26/2014)... consumers, and suppliers has prompted manufacturers to set ... they emit from their smokestacks or discharge into ... environmental performance at every step in their process, ... use and recycling of their products. , This ... as life cycle engineering, which connects the engineers ...
(Date:8/26/2014)... University of Illinois engineers are bringing a ... researchers developed a new continuous glucose monitoring material ... the wavelength shift is so precise that doctors ... for automatic insulin dosing - something not ... , "There are significant limitations to current continuous ...
Breaking Biology News(10 mins):Lack of naturally occuring protein linked to dementia 2Yale journal explores advances in sustainable manufacturing 2A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3
... therapies often succeed at initially eliminating the bulk ... but are eventually thwarted because they cannot eliminate ... cancer stem cells, which ultimately become the source ... by scientists at the University of Pittsburgh School ...
... New research from Colorado State University shows that the ... circadian -- or daily -- rhythms. The study, publishing ... current theory that only 10 percent to 15 percent ... scientists have long known that circadian rhythms regulate the ...
... temples and cultivated for its wood and cottony fibers, ... biologists have clung to for decades: the notion that ... continents were connected 96 million years ago. , Research ... colleagues shows that kapok---and perhaps other rainforest--trees colonized Africa ...
Cached Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Research finds that circadian rhythms dominate all life functions 2Research finds that circadian rhythms dominate all life functions 3The kapok connection -- Study explains rainforest similarities 2
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
Biology Products: